Krescent Program

Kidney Research Scientist Core Education and National Training Program

You do not have the latest version of Flash installed, click the button below to install Flash.

Get Adobe Flash player

Welcome from the Program Director

Welcome to the new website of the KRESCENT Program.  It gives me great pleasure to introduce the Kidney Research Scientist Core Education and National Training Program, better known as KRESCENT Read more...

 

Reduced Kidney Function with Proteinuria Associated With Increased Risk of Kidney Failure

Patients with high levels of  protein in the urine (proteinuria) coupled with at least one other marker of reduced kidney function had a higher risk of death, heart attack and progression to kidney failure according to a recent study published in the Journal of the American Medical Association (JAMA) co-authored by Dr. Matthew James. Dr. James is a Post-Doctoral Fellowship recipient of the landmark Kidney Research Scientist Core Education and National Training (KRESCENT) Program made possible by The Kidney Foundation and a team of collaborators.  Read more...

Latest News
KRESCENT Trainees Shine
at ASN Renal Week 2009
Dr. Adeera Levin
Appointed 2010 Secretary General of International Society of Nephrology (ISN)
Featured Publications
Jean-Philippe Lafrance publishes Pharmacoepidemiology and Drug Safety:
Selective and non-selective non-steroidal anti-inflammatory drugs and the risk of acute kidney injury.
Darren Yuen publishes in Hypertension:
The (Pro)Renin Receptor. Site-Specific and Functional Linkage to the Vacuolar H+-ATPase in the Kidney.
Mélanie Béland publishes in Molecular cancer research:
Calcineurin a-binding protein, a novel modulator of the calcineurin-nuclear factor of activated T-cell signaling pathway, is overexpressed in wilms' tumors and promotes cell migration.
Michael Walsh publishes in Kidney International:
Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis.
Lakshman Gunaratnam publishes in Journal of translational medicine:
TRIP-Br2 promotes oncogenesis in nude mice and is frequently overexpressed in multiple human tumors.

The KRESCENT Program is a Strategic Training Program developed and supported by :

 


With additional generous support from :

 AMGEN

 Baxter Corporation

 Merck-Frosst Canada Ltd.

 Ortho Biotech

 Roche

 Shire BioChem Inc.

 
© 2005 The Kidney Foundation of Canada